142 related articles for article (PubMed ID: 36244815)
21. Tired of Being Ignored: Fatigue as a Presenting Symptom in Primary Hyperparathyroidism.
Montgomery KB; Fazendin JM; Lindeman B; Chen H
J Surg Res; 2021 Jul; 263():53-56. PubMed ID: 33639369
[TBL] [Abstract][Full Text] [Related]
22. Predictors of bone mineral density improvement in patients undergoing parathyroidectomy for primary hyperparathyroidism.
Sharma J; Itum DS; Moss L; Li C; Weber C
World J Surg; 2014 Jun; 38(6):1268-73. PubMed ID: 24744114
[TBL] [Abstract][Full Text] [Related]
23. Normocalcemic hyperparathyroidism: A Collaborative Endocrine Surgery Quality Improvement Program analysis.
Pandian TK; Lubitz CC; Bird SH; Kuo LE; Stephen AE
Surgery; 2020 Jan; 167(1):168-172. PubMed ID: 31543325
[TBL] [Abstract][Full Text] [Related]
24. Letter to the Editor: Parathyroidectomy for Normocalcemic Primary Hyperparathyroidism (nPHPT) is Associated with Improved Bone Mineral Density Regardless of Postoperative Parathyroid Hormone Levels.
Jagannath S; Mayilvaganan S; Idrees S
World J Surg; 2023 Mar; 47(3):829. PubMed ID: 36480058
[No Abstract] [Full Text] [Related]
25. Clinical profile of juvenile primary hyperparathyroidism: a prospective study.
Saponaro F; Marcocci C; Cacciatore F; Miccoli M; Pardi E; Borsari S; Materazzi G; Miccoli P; Cetani F
Endocrine; 2018 Feb; 59(2):344-352. PubMed ID: 28527123
[TBL] [Abstract][Full Text] [Related]
26. Parathyroidectomy for Normocalcemic Tertiary Hyperparathyroidism: A 19-Year Experience.
Ramonell KM; Lindeman B; Chen H; Fazendin J
J Surg Res; 2022 Aug; 276():362-368. PubMed ID: 35429685
[TBL] [Abstract][Full Text] [Related]
27. [Primary hyperparathyroidism. Postoperative normocalcemic hyperparathyrinemia after curative parathyroidectomy].
Hermann M
Chirurg; 2010 May; 81(5):447-53. PubMed ID: 19468699
[TBL] [Abstract][Full Text] [Related]
28. Parathyroidectomy for nephrolithiasis in primary hyperparathyroidism: Beneficial but not a panacea.
Huang SY; Burchette R; Chung J; Haigh PI
Surgery; 2022 Jan; 171(1):29-34. PubMed ID: 34364687
[TBL] [Abstract][Full Text] [Related]
29. Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism.
Koumakis E; Souberbielle JC; Sarfati E; Meunier M; Maury E; Gallimard E; Borderie D; Kahan A; Cormier C
J Clin Endocrinol Metab; 2013 Aug; 98(8):3213-20. PubMed ID: 23783096
[TBL] [Abstract][Full Text] [Related]
30. Elevated parathyroid hormone one year after kidney transplantation is an independent risk factor for graft loss even without hypercalcemia.
Okada M; Tominaga Y; Sato T; Tomosugi T; Futamura K; Hiramitsu T; Ichimori T; Goto N; Narumi S; Kobayashi T; Uchida K; Watarai Y
BMC Nephrol; 2022 Jun; 23(1):212. PubMed ID: 35710357
[TBL] [Abstract][Full Text] [Related]
31. Current opinions on nephrolithiasis associated with primary hyperparathyroidism.
Cong X; Shen L; Gu X
Urolithiasis; 2018 Oct; 46(5):453-457. PubMed ID: 29350243
[TBL] [Abstract][Full Text] [Related]
32. Parathyroidectomy for Normocalcemic Primary Hyperparathyroidism Improves Bone Mineral Density Regardless of Postoperative Parathyroid Hormone Levels.
Lui MS; Perrier ND
World J Surg; 2023 Mar; 47(3):830-831. PubMed ID: 36622434
[No Abstract] [Full Text] [Related]
33. Operative intervention for primary hyperparathyroidism offers greater bone recovery in patients with sporadic disease than in those with multiple endocrine neoplasia type 1-related hyperparathyroidism.
Silva AM; Vodopivec D; Christakis I; Lyons G; Wei Q; Waguespack SG; Petak SM; Grubbs E; Lee JE; Perrier N
Surgery; 2017 Jan; 161(1):107-115. PubMed ID: 27842919
[TBL] [Abstract][Full Text] [Related]
34. Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism.
Beysel S; Caliskan M; Kizilgul M; Apaydin M; Kan S; Ozbek M; Cakal E
BMC Cardiovasc Disord; 2019 May; 19(1):106. PubMed ID: 31068134
[TBL] [Abstract][Full Text] [Related]
35. Early biochemical response to parathyroidectomy for primary hyperparathyroidism and its predictive value for recurrent hypercalcemia and recurrent primary hyperparathyroidism.
Ryder CY; Jarocki A; McNeely MM; Currey E; Miller BS; Cohen MS; Gauger PG; Hughes DT
Surgery; 2021 Jan; 169(1):120-125. PubMed ID: 32768241
[TBL] [Abstract][Full Text] [Related]
36. Focused parathyroidectomy with intraoperative parathyroid hormone monitoring in patients with lithium-associated primary hyperparathyroidism.
Wade TJ; Yen TW; Amin AL; Evans DB; Wilson SD; Wang TS
Surgery; 2013 May; 153(5):718-22. PubMed ID: 23352236
[TBL] [Abstract][Full Text] [Related]
37. Effects of parathyroidectomy on kidney function in patients with primary hyperparathyroidism: Results of a prospective study.
Frey S; Wargny M; Blanchard C; Caillard C; Hadjadj S; Cariou B; Figueres L; Mirallié E
Surgery; 2023 Jan; 173(1):146-153. PubMed ID: 36167701
[TBL] [Abstract][Full Text] [Related]
38. The phenotype of primary hyperparathyroidism with normal parathyroid hormone levels: how low can parathyroid hormone go?
Wallace LB; Parikh RT; Ross LV; Mazzaglia PJ; Foley C; Shin JJ; Mitchell JC; Berber E; Siperstein AE; Milas M
Surgery; 2011 Dec; 150(6):1102-12. PubMed ID: 22136828
[TBL] [Abstract][Full Text] [Related]
39. Characterizing the operative findings and utility of intraoperative parathyroid hormone (IOPTH) monitoring in patients with normal baseline IOPTH and normohormonal primary hyperparathyroidism.
Trinh G; Noureldine SI; Russell JO; Agrawal N; Lopez M; Prescott JD; Zeiger MA; Tufano RP
Surgery; 2017 Jan; 161(1):78-86. PubMed ID: 27863787
[TBL] [Abstract][Full Text] [Related]
40. Systems-Level Opportunities in the Management of Primary Hyperparathyroidism: An Informatics-based Assessment.
Dawood NB; Tseng CH; Nguyen DT; Yan KL; Livhits MJ; Leung AM; Yeh MW
J Clin Endocrinol Metab; 2021 Nov; 106(12):e4993-e5000. PubMed ID: 34313755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
